Form F-10 - Registration Statement for Securities of certain Canadian Issuers.:
SEC Accession No. 0001144204-18-022351
Filing Date
2018-04-25
Accepted
2018-04-25 15:54:16
Documents
7

Document Format Files

Seq Description Document Type Size
1 F-10 tv491991_f10.htm F-10 221687
2 EXHIBIT 5.1 tv491991_ex5-1.htm EX-5.1 5578
3 GRAPHIC image_001.jpg GRAPHIC 4562
4 GRAPHIC image_002.jpg GRAPHIC 4953
5 GRAPHIC image_003.jpg GRAPHIC 33295
6 GRAPHIC image_004.jpg GRAPHIC 29700
7 GRAPHIC image_005.jpg GRAPHIC 21245
  Complete submission text file 0001144204-18-022351.txt   358060
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: F-10 | Act: 33 | File No.: 333-224432 | Film No.: 18774307
SIC: 2834 Pharmaceutical Preparations